INTERNATIONAL PATENT: CARBIOGENE THERAPEUTICS CO., LTD., 浙江康佰裕生物科技有限公司 FILES APPLICATION FOR "CLAUDIN 18.2-TARGETING CHIMERIC ANTIGEN RECEPTOR FUSED WITH CHIMERIC SWITCH RECEPTOR, IMMUNE CELL MODIFIED THEREBY AND USE THEREOF"

GENEVA, Jan. 11 -- CARBIOGENE THERAPEUTICS CO., LTD. (Floor 20, Building No. 5, 688 Bin'an Road, Binjiang DistrictHangzhou, Zhejiang 310051), 浙江康佰裕生物科技有限公司 (中国浙江省杭州市滨江区滨安路688号5幢20层) filed a patent application (PCT/CN2025/091685) for "CLAUDIN 18.2-TARGETING CHIMERIC ANTIGEN RECEPTOR FUSED WITH CHIMERIC SWITCH RECEPTOR, IMMUNE CELL MODIFIED THEREBY, AND USE THEREOF" on Apr 28, 2025. With publication no. WO/2026/007513, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submi...